Cardiovision International Tech, S.a.s. De C.v.
Clinical trials sponsored by Cardiovision International Tech, S.a.s. De C.v., explained in plain language.
-
Can a new care pathway speed up advanced heart failure decisions?
Disease control Not yet recruitingResearchers are testing whether a standardized care pathway helps adults with advanced heart failure in Latin America complete a multidisciplinary evaluation and receive a documented treatment decision within 90 days. The trial includes 360 adults with acquired or structural hear…
Sponsor: CardioVision International Tech, S.A.S. de C.V. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
A new roadmap to transplant: could standardizing care save more congenital heart patients?
Disease control Not yet recruitingThis trial tests a structured care pathway called TORCH-ITAP in Latin America. The pathway standardizes how patients with congenital heart disease are identified, referred, evaluated, and matched for heart or lung transplants. Researchers will compare hospitals using the pathway …
Sponsor: CardioVision International Tech, S.A.S. de C.V. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC